A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN

NCT04667013 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Guangzhou Magpie Pharmaceuticals Co., Ltd.